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Abstract
Amyloid b-peptide (Ab) accumulation leads to neurodegeneration and Alzheimer’s disease (AD). Ab metabolism is a
dynamic process in the Ab production and clearance that requires neprilysin (NEP) and other enzymes to degrade Ab. It has
been reported that NEP expression is significantly decreased in the brain of AD patients. Previously we have documented
hypoxia is a risk factor for Ab generation in vivo and in vitro through increasing Ab generation by altering b-cleavage and c-
cleavage of APP and down-regulating NEP, and causing tau hyperphosphorylation. Here, we investigated the molecular
mechanisms of hypoxia-induced down-regulation of NEP. We found a significant decrease in NEP expression at the mRNA
and protein levels after hypoxic treatment in mouse primary cortical and hippocampal neurons. Chromatin
immunoprecipitation (ChIP) assays and relative quantitative PCR (q-PCR) revealed an increase of histone H3-lysine9
demethylation (H3K9me2) and a decrease of H3 acetylation (H3-Ace) in the NEP promoter regions following hypoxia. In
addition, we found that hypoxia caused up-regulation of histone methyl transferase (HMT) G9a and histone deacetylases
(HDACs) HDAC-1. Decreased expression of NEP during hypoxia can be prevented by application with the epigenetic
regulators 5-Aza-29-deoxycytidine (5-Aza), HDACs inhibitor sodium valproate (VA), and siRNA-mediated knockdown of G9a
or HDAC1. DNA methylation PCR data do not support that hypoxia affects the methylation of NEP promoters. This study
suggests that hypoxia may down-regulate NEP by increasing H3K9me2 and decreasing H3-Ace modulation.
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Introduction
A neuropathological hallmark of Alzheimer’s disease (AD) is the
presence of amyloid b-peptide (Ab) plaques, composed mainly of
Ab1-42, and the excessive accumulation of Ab1-42 is believed to
be responsible for the initial event of neurodegeneration in AD [1].
Previously we have documented that hypoxia is a risk factor for Ab
generation in vivo and in vitro through increasing Ab generation
by altering b- cleavage and c-cleavage of amyloid precursor
protein (APP) and down-regulating NEP, and causing tau
hyperphosphorylation [2], [3]. NEP is a synaptic enzyme which
is found to play a major role in the clearance of Ab from the brain
[4]. The levels of NEP are declined with aging and hypoxic
condition, two of the high risk factors for AD [5], [6]. The
decrease in NEP expression has been linked to alteration in Ab
clearance leading to Ab accumulation, which is considered to be
an important event contributing to the development and
progression of AD [7].
Hypoxia is one of the major common pathophysiology risk
factor for diabetes,stroke, hypertension, atherosclerosis, AD and
other diseases [8]. Patients suffering from cerebral ischemia and
stroke in which hypoxic conditions occur are much more
susceptible to AD [9]. Hypoxia inducible factor (HIF) is one of
the early response molecules to hypoxic condition and HIF and its
pathways participate in many pathological processes of diseases
including AD [2], [10], and over 300 genes are regulated by HIF
[11]. Several studies including ours have demonstrated that
hypoxia increases the production of Ab [2], [10], decreases the
clearance of Ab from brain [12] and increases tau phosphorylation
[13]. Epigenetic changes play a key role in hypoxia-mediated gene
expression change at transcriptional levels [14]. The methylation
of CpG islands in the promoter regions of genes can result in the
silenced expression [15]. Post-translational modification of his-
tones by regulating cellular gene expression plays a critical role in
sustained CpG island methylation [16]. Further, it has been
reported that DNA methyltransferase inhibitor 5-Aza reduced the
level of H3-K9 methylation in the promoter region of tumor
suppressor gene independently of cytosine methylation [17],
suggesting a novel function of 5-Aza in histone modification. It
has also been demonstrated that post-translational modification of
histones can control gene activity. The methylation and acetyla-
tion of lysine residues in histones by specific histone methyltrans-
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been implicated in the alterations of chromatin structure and gene
regulation. The methylation of K9 and demethylation of K4 in
histone 3 has been associated with condensed chromatin and the
silencing of genes [19], and the deacetylation of lysine in histone 3
has been linked to chromatin condensing and gene silencing [18].
In the present study, we have shown that hypoxia causes
significant down-regulation of NEP expression, which can be
prevented by methylation inhibitor 5-Aza, HDAC inhibitor VA,
and siRNA-mediated knockdown of G9a or HDAC1. Our results
suggest that chromatin remodeling of crucial AD-related genes by
5-Aza, VA and G9a or HDAC1 inhibitors could provide new
therapeutic strategy for AD.
Results
Hypoxia inhibits the expression of NEP at the mRNA and
protein levels
In order to detect whether hypoxia can affect the expression of
NEP, NEP expression was detected by real-time PCR and Western
blot after hypoxic treatment for 12 h, 24 h and 48 h in mouse
primary cortical and hippocampal neurons and astrocytes. Our
results showed that hypoxia significantly inhibited the expression of
NEP both at the mRNA and protein levels (Figure 1A–C) in mouse
primary cortical and hippocampal neurons after hypoxic treatment
for 24 h and 48 h. But in astrocytes hypoxia did not affect the
expression of NEP (Figure 1A–C).
Theepigenetic regulators5-Aza andVA were utilizedto examine
the epigenetic role in the down-regulation of NEP by hypoxia at the
mRNA and protein levels. We found that 5-Aza and VA prevented
the down-regulation of NEP by hypoxia (Figure 1D–F). 5-Aza may
prevent the down-regulation of NEP via inhibiting cytosine
methylation [20], diminishing H3-K9 methylation [17], augment-
ing H3 acetylation and H3-K4 methylation [21], while VA may
prevent the down-regulationof NEP via augmenting H3 acetylation
by inhibiting HDACs [22]. These results suggest that either
histone/DNA methylation or histone deacetylation is involved in
the down-regulation of NEP by hypoxia.
Histone methylation is involved in hypoxia-induced
downregulation of NEP
Since H3K9me2 is known to cause gene silencing [17], we
further determined the H3K9me2 status during hypoxia. We
found that H3K9me2 levels were significantly increased in mouse
primary cortical and hippocampal neurons after hypoxic treat-
ment for 24 h and 48 h (Figure 2A, B). As H3-K4 trimethylation
(H3K4me3) was reported to be involved in gene activation [17],
we examined H3K4me3 levels in the mouse primary cortical and
Figure 1. Hypoxia inhibits the expression of NEP at the protein and mRNA levels. (A) NEP mRNA expression was determined by real-time
PCR. Primary cortical and hippocampal neurons and astrocytes were incubated under the condition of normoxia or hypoxia for 12 h, 24 h, and 48 h.
NEP mRNA transcript levels in normoxic control cells were normalized against GAPDH. (B, C) Primary cortical and hippocampal neurons and
astrocytes were incubated under the condition of normoxia or hypoxia for 12 h, 24 h, and 48 h. The protein of b-actin was blotted as control.
(D) Primary cortical and hippocampal neurons were incubated under the condition of normoxia or hypoxia for 24 h. Cells were treated with 5-Aza
(100 mM) and VA (10 mM) before hypoxia. NEP mRNA transcript levels in normoxic control cells were normalized against GAPDH. (E, F) Primary
cortical and hippocampal neurons were cultured for 24 h in the presence of 5-Aza, VA or no drug. As control, the protein levels of b-actin were
blotted with anti-b-actin antibody. Data are expressed as mean 6 SD from four separate experiments. *P,0.05, **P,0.01 as compared with Sham;
#P,0.05 as compared with H24h. O.D., optical density; Sham, normoxia; H, hypoxia; 5-Aza, 5-Aza-2-deox-ycyti-dine; VA, sodium valproate; GAPDH,
glyceraldehydes-3- phosphate dehydrogenase.
doi:10.1371/journal.pone.0019229.g001
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H3K4me3 was partly diminished following hypoxia in the mouse
primary cortical and hippocampal neurons (Figure 2C, D). To
determine whether hypoxia-induced H3-K9me2 increase was
attributed to NEP down-regulation, we performed the ChIP assay
using anti-H3-K9me2 antibody and q-PCR assay. Since NEP
expression can be regulated through two distinct promoters called
NEP promoter-1 and promoter-2 [23], [24], we measured the
interactivity of H3K9me2 with the two promoters. We revealed
that under hypoxic condition H3K9me2 levels in the NEP
promoter-1 and promoter-2 regions were significantly increased in
the cultures of cortical and hippocampal neurons. These results
indicate that hypoxia can induce histone methylation in NEP
promoters regions, resulting in down-regulation of NEP expression
(Figure 2E, F).
Recently, it has been reported that G9a could modulate
H3K9me2 under hypoxic condition [25], [26]. Thus, we
investigated whether the H3K9me2 in the NEP promoter-1 and
promoter-2 regions were mediated by G9a. Our result showed
that the G9a levels were increased in the primary cortical and
hippocampal neurons following hypoxic treatment. The change in
G9a protein levels was correlated with that of H3K9me2
(Figure 2A, B). To determine whether G9a was crucial for
hypoxia-induced NEP down-regulation, we adopted a small
interfering (si) RNA strategy. We transfected mouse primary
cortical and hippocampal neurons with a siRNA of G9a to
knockdown G9a and a scrambled siRNA of G9a as a control. As
shown in Figure 3A–D, transfection with G9a siRNAs attenuated
the hypoxia-induced increase in G9a expression by 30%–42% and
H3K9me2 expression by 34%–63% in the primary cortical and
hippocampal neurons, respectively; and G9a siRNAs transfection
prevented the hypoxia-induced decrease in NEP by 35% and 24%
in the primary cortical and hippocampal neurons, respectively;
while transfection with scrambled siRNA of G9a seemed no
interference with the expressions of G9a, H3K9me2 and NEP
(Figure 3A–D). In addition, we performed an immunocytochem-
istry study in the neuronal cultures, illustrating that siRNA G9a
transfection prevented the hypoxia-induced H3K9me2 up-regu-
lation, which was correlated with the results from Western blot
(Figure 3E). Our findings suggest that hypoxia suppresses
expression of NEP through the histone methylation by G9a.
Histone deacetylation is involved in hypoxia-induced
down-regulation of NEP
Histone deacetylation is known to be involved in gene silencing
[17] and HDAC1 is the most important histone deacetylase.
Therefore we determined the H3-Ace and HDAC1 status in the
primary cortical and hippocampal neurons under the hypoxic
condition. We found that histone acetylation was significantly
decreased while HDAC1 was significantly increased in the neuronal
cultures after treatment for 24 h or 48 h of hypoxia (Figure 4A, B).
H3-Ace and HDAC1 expressions were inversely correlated after
24 h or 48 h of hypoxia in the neuronal cultures (Figure 4A, B).
To verify whether histone acetylation under hypoxic condition
can result in NEP down-regulation, we performed ChIP assay and
q-PCR to determine the interaction of H3-Ace and NEP
promoters. As shown in Figure 4C and D, hypoxia decreased
the binding of H3-Ace to the NEP promoters. Compared to the
input control, promoter H3-Ace was lower in the normoxia-
treated cultures than in hypoxia-treated ones. These results
indicate that hypoxia could induce histone deacetylation through
NEP promoter regions, leading to down-regulation of NEP
expression (Figure 4C, D).
It has been reported that HDAC1 can modulate histone
deacetylation under hypoxic condition [25], [26]. Thus, we
investigated whether HDAC1 contributes to in the histone
deacetylation of NEP promoters in association with hypoxia-induced
NEP down-regulation. We transfected mouse primary cortical and
hippocampal neurons with a siRNA of HDAC1 to knockdown
HDAC1 and a scrambled siRNA of HDAC1 as a control. As shown
in Figure 5A–D, the treatment with HDAC1 siRNAs significantly
attenuated the hypoxia-induced increase in the expression of
HDAC1 by 62% and 41% in the primary cortical and hippocampal
neurons, respectively. Further, the treatment with HDAC1 siRNAs
significantly prevented the hypoxia-induced decrease in the expres-
sions of H3-Ace and NEP by 29%–36% and 27%–31% in mouse
primary cortical and hippocampal neurons, respectively (Figure 5A–
D). Application of scrambled siRNA of HDAC1 seemed no
interference with the expressions of HDAC1, H3-Ace and NEP
(Figure 5A–D). In addition, we performed an immunocytochemistry
study in the neuronal cultures, illustrating the HDAC1 siRNA
prevented the hypoxia-induced H3-Ace down-regulation, which was
correlated with the results from Western blot (Figure 5E). These
findings suggest that hypoxia can suppress NEP expression through
histone deacetylation by HDAC1.
DNA promoters methylation in hypoxia-induced down
regulation of NEP
To determine whether hypoxia can regulate DNA methylation
of NEP promoters, we performed methylation-specific PCR assay
with the primers designed to amplify NEP promoter regions in the
mouse primary cortical and hippocampal neurons. The results
showed no obvious change in the levels of unmethylation-specific
PCR and methylation-specific PCR under 48 h hypoxic condition
as compared with normoxic treatment, suggesting that there was
no evidence of hypoxia-induced methylation at CpG sites
(Figure 6A). Next we detected the levels of DNMT1 and
DNMT3a and found that both of them were significantly
increased in the primary hippocampal neurons after hypoxic
treatment for 24 h and 48 h, but were only significantly increased
in the cortical neurons after hypoxic treatment for 48 h (Figure 6B,
C). These results indicate that hypoxia induces significantly
changes in DNMT1 and DNMT3a expressions, but the DNA
methylation PCR data do not support that hypoxia affects the
methylation of NEP promoters.
Discussion
Abnormal deposition of Ab in brain is the most significant and
important pathological hallmark of AD. Late-onset forms of AD
might be primarily attributed to deficiency in the clearance of Ab
rather than its formation [1]. Ab accumulation has been shown in
part by the down regulation of several enzymes associated with
degradation, including NEP. The NEP plays a major role in the
clearance of Ab from the brain [4], [27], [27], and over-expression
of NEP is found to significantly reduce the Ab burden in
transgenic AD mice [28]. Increasing lines of evidence suggest that
NEP levels in the brain declines with aging and chronic hypoxia,
and the decreased NEP levels may lead to the reduction in Ab
clearance which may contribute the development and progression
of AD [12], [29]. It is well documented that hypoxia is a risk factor
for Ab generation in vivo and in vitro through increasing Ab
generation by altering b-cleavage and c-cleavage of APP and
down-regulating NEP, and possible other pathways [2], [3]. Our
results suggest that hypoxia affects the NEP expression both at
mRNA and protein levels by regulating the histone methylation
and histone deacetylation.
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19229Figure 2. Hypoxia increases histone H3-K9me2 and G9a, but decreases H3K4me3. (A, B) H3K9me2 and G9a of primary cortical and
hippocampal neurons were detected by Western blot analysis at 24 h and 48 h after hypoxia. b-actin was used as control. (C, D) H3K4me3 was
detected by Western blot analysis at 24 h and 48 h after hypoxia. Data are expressed as mean 6 SD from four separate experiments. *P,0.05,
**P,0.01 as compared with Sham; #P,0.05 as compared with H24 h. (E, F) ChIP and q-PCR analysis were performed with an anti-H3K9me2 antibody
and primers amplifying the NEP promoter-1 and promoter-2 regions; the bands illustrate the levels of H3K9me2 in the NEP promoter-1 and promoter-
2 regions. Ip represents amplification of total input DNA from whole neurons. H3K9 represents DNA bound to H3K9me2 in the sample. Results from
four separate experiments are presented as the ratio of H3K9 to Ip. *P,0.05, **P,0.01 as compared with Sham; Sham, normoxia; H, hypoxia.
doi:10.1371/journal.pone.0019229.g002
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be a crucial component in the development of complex brain
disorders [30]. Indeed, it has been reported that epigenetic
mechanisms play an important role in AD [31]. Furthermore,
oxidative stress and hypoxia which are the common pathophys-
iologic contributors in AD [32] have been shown to modulate
DNA methylation and histone methylation [33]. Analyses of DNA
methylation and histone modulation in genes associated with AD
from patients’ prefrontal cortex and lymphocytes have revealed
abnormal profiles [33]. An age-specific epigenetic drift associated
with unusual methylation patterns in late-onset forms of AD has
been identified, supporting a potential epigenetic role in the
development of AD [34]. Yet, increasing lines of evidence indicate
that age and hypoxia may influence epigenetic drift in AD [35].
DNA methylation and demethylation is one of the mechanisms
operating in the epigenetic regulation of gene expression. A few studies
have shown that DNA methylation of the NEP promoters do not
mediate its transcriptional repression in the neuronal lines [36] or in
hepatobiliary cells in Alagille syndrome [37]. Meanwhile, hypoxic
silencing of RUNX3 may not result from DNA promoter methylation
[25]. The epigenetic regulator 5-Aza is known for its ability to inhibit
cytosine methylation [20]. Some studies have also demonstrated that 5-
Figure 3. Hypoxia increases histone H3-K9me2 through G9a accumulation. (A, B, C, D) Primary cortical and hippocampal neurons were
transfected with G9a siRNA, followed by hypoxic exposure for 24 h. G9a, H3K9me2 and NEP protein levels were evaluated by Western blot. The G9a
siRNA decreased the expression of G9a, decreased the expression of H3K9me2, and increased the expression of NEP. As control, a-tubulin was
blotted. Data are expressed as mean 6 SD from four separate experiments. *P,0.05, **P,0.01 and ***P,0.001 as compared with Sham; #P,0.05,
##P,0.01 as compared with H24 h. (E) Immunocytochemical detection of H3K9me2 of primary cortical neurons. (a) Sham. (b) Hypoxia.
(c) Transfected with scrambled G9a siRNA as control. (d) Transfected with G9a siRNA. Cells were stained with antibody against H3K9me2 followed by
a FITC-labeled secondary antibody. The G9a siRNA prevented the hypoxia induced up-regulation of H3K9me2. Magnification: 4006. Scale bar, 20 mm.
O.D., optical density; Sham, normoxia; H24 h, hypoxia 24 h; Sc-siRNA, scrambled siRNA of G9a; siRNA, siRNA of G9a.
doi:10.1371/journal.pone.0019229.g003
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H3-K9 methylation and augmenting H3 acetylation and H3-K4
methylation, independently of its effects on DNA methylation or gene
expression [17], [21]. It has also been reported that hypoxia can result
in the down-regulation of MLH1 and RUNX3 by histone H3K9me2
through G9a [25], [26], [38] or through inhibiting histone
demethylases JHDM2A or JMJD1A [39]. In our study, we found
that hypoxia significantly increases the expressions of DNMT1 and
DNMT3a, but does not affect the methylation of NEP promoters
(Figure 6A). All the results indicate that 5-Aza may reverse hypoxia-
induced down-regulation of NEP by diminishing H3-K9 methylation
and augmenting H3 acetylation and H3-K4 methylation.
Post-translational modification of the N-terminal group of
histone lysine residues by acetylation or deacetylation can regulate
gene activity. HDACs especially HDAC1 play a critical role in
sustained histone deacetylation in the gene promoter. Although
much attention has focused on the potential function of HDACs in
cancer research, recently there have been several studies showing
their involvement in neurodegenerative diseases [22]. HDACs
inhibitors can enhance the clearance of Ab from brain [40] by
inducing expression of plasmin [12], inhibit the Ab production
and neuritic plaque formation [41], and reverse the contextual
memory deficits in a mouse model of AD [42]. In this study, we
have demonstrated that hypoxia is able to reduce H3-Ace in the
NEP promoters by enhancing HDAC1. However, the role of
hypoxia in the neuropathology of AD is yet to be determined.
In summary, we have shown that hypoxia causes significant
down-regulation of NEP expression by increasing H3K9me2,
H3K4me3 and decreasing H3-Ace modulation, which can be
prevented by the epigenetic regulators 5-Aza, HDACs inhibitor
VA, siRNA-mediated knockdown of G9a or HDAC1. Chromatin
remodeling of crucial AD related genes by 5-Aza, VA, and siRNA-
mediated knockdown of HDAC1 or G9a can provide new
therapeutic strategy for AD.
Figure 4. Hypoxia decreases H3-Ace and increases HDAC1 expression. (A, B) H3-Ace and HDAC1 of primary cortical and hippocampal
neurons were detected at 24 h and 48 h by Western blot analysis. Exposure to hypoxia for 24 h and 48 h decreased H3-Ace, but increased the level of
HDAC1. As control, a-tubulin was blotted. Data are expressed as mean 6 SD from four separate experiments. *P,0.05, **P,0.01 as compared with
Sham; #P,0.05, ##P,0.01 as compared with H24 h. (C, D) ChIP and q-PCR analysis were performed with an anti-H3-Ace antibody and primers
amplifying the NEP promoter-1 and promoter-2 regions; the bands illustrate the levels of H3-Ace in the NEP promoter-1 and promoter-2 regions.
Ip represents amplification of total input DNA from whole cell lysate. H3-Ace represents DNA bound to H3-Ace in the sample. Results from four
separate experiments are presented as the ratio of H3-Ace to Ip. *P,0.05, **P,0.01 as compared with Sham; Sham, normoxia; H24 h, hypoxia 24 h.
doi:10.1371/journal.pone.0019229.g004
Hypoxia Decreased the Expression of Neprilysin
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e19229Materials and Methods
Mouse primary cortical and hippocampal neuron and
astrocyte cultures
Animal care and procedures were performed in accordance
with the Laboratory Animal Care Guidelines approved by
Shanghai Institutes for Biological Sciences of Chinese Academy
of Sciences. Permit numbers: SCXK (HU) 2007–0005; SYXK
(HU) 2008–0049. This study was approved by Science and
Technology Commission of Shanghai Municipality.
The C57 mouse primary cortical and hippocampal neurons and
astrocytes were prepared according to previously described proce-
dures. Briefly, primary cortical and hippocampal neurons and
astrocytesweregrownfromdissociated cellsderived from the cerebral
cortex and hippocampus of 24 h old C57 mouse (Experimental
Animal Center of Shanghai). After the cerebral cortex and
hippocampus were removed and meninges and microvessels were
cleaned, the cortex and hippocampus tissues were cut into 1–2 mm
3
pieces and then digested with 0.05% trypsin-EDTA (Sigma, USA)
and 0.01% DNase I (Sigma, USA) at 37uCf o r1 5 m i n ,t h e n
Figure 5. Hypoxia decreases H3-Ace through HDAC1 accumulation. (A, B, C, D) Primary cortical and hippocampal neurons were transfected
with HDAC1 siRNA, followed by hypoxic exposure for 24 h. HDAC1, H3-Ace and NEP protein levels were evaluated by Western blot. The HDAC1 siRNA
decreased the expression of HDAC1, increased the expression of H3-Ace, and increased the expression of NEP. As control, the protein a-tubulin was
blotted. Data are expressed as mean 6 SD from four separate experiments. *P,0.05, **P,0.01 and ***P,0.001 as compared with Sham; #P,0.05,
##P,0.01 as compared with H24 h. (E) Immunocytochemical detection of H3-Ace of primary cortical neurons. (a) Sham. (b) Hypoxia. (c) Transfected
with scrambled HDAC1 siRNA as control. (d) Transfected with HDAC1 siRNA. Neurons were stained with antibody against H3-Ace followed by a FITC-
labeled secondary antibody. The HDAC1 siRNA prevented the hypoxia induced down-regulation of H3-Ace. Magnification: 4006. Scale bars, 20 mm.
O.D., optical density; Sham, normoxia; H24 h, hypoxia 24 h; Sc-siRNA, scrambled siRNA of HDAC1; siRNA, siRNA of HDAC1.
doi:10.1371/journal.pone.0019229.g005
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Neurobasal
TM medium (Gibco, USA), supplemented with 10% FCS
(Gibco, USA), 2% (f/c) B-27 supplement (Gibco, USA), 5 mM (f/c)
L-glutamine (Sigma, USA), and 10 mg/ml gentamycin (Sigma,
USA). After mechanical dissociation, centrifugation, and resuspen-
sion, the cells were seeded in 6-well or 24-well tissue culture plates
(Coning, USA) pre-coated overnight with poly-L-lysine (Sigma,
USA)) at a density of 1 610
5/cm
2. After culture for 2 weeks, these
preparations were referred to as ‘‘neuronal cultures’’ to contain over
90% neurons as illustrated by MAP2 immunostaining [43]. Cells
were treated with 5-Aza (100 mM) and VA (10 mM) before hypoxia.
For preparation of astrocytes, B-27 wasn’t added to the
medium. After culture for 2 weeks, the astrocytes in flasks
(Coning, USA) were shaken at 190 rpm for 18 h at 37uCt o
remove microglia and oligodendrocytes, and the adherent cells
were allowed to grow for another 3 days. Then, flasks were shaken
again under the same conditions to remove the remaining
microglia and oligodendrocytes. Next, the attached cells were
digested with 0.25% trypsin-EDTA and transferred to 6-well
plates at a density of 1.5610
5/cm
2. Using GFAP immunostaining
we documented nearly 95% cells GFAP-positive astrocytes [44].
Hypoxic stress
To study the effect of hypoxia on expression and localization of
proteins of interest, the C57 mouse primary cortical and hippocampal
neurons and astrocytes were incubated in an O2/N2/CO2 incubator
MCO-M (Sanyo, Japan) for 12 h, 24 h or 48 h under 1% O2 in
accordance with previous reports [45]. The cells were collected 12 h,
24 h or 48 h later, washed twice with 10 ml phosphate buffered Saline
(PBS, pH 7.2), scraped into 10 ml of PBS and pelleted at 3,000 g for
5 min. Pellets were resuspended in 66vol of 50 mM Tris-1% Triton
X-100 (pH 7.4) buffer containing an EDTA free cocktail of protease
inhibitors in the concentration suggested by the manufacturer and
lysed for 30 min at 4uC. Cell lysates were centrifuged at 12000 g for
Figure 6. Methylation of NEP promoter regions and DNMT levels. (A) Methylation-specific PCR analysis of the NEP promoter-1 and
promoter-2 regions were performed with genomi cDNA isolated as described in materials and methods. Methylation was detected by the presence of
PCR product amplified by methylation-specific primers in the Meth lane; demethylation was detected using PCR products amplified with
unmethylated-specific primers in the Ume lane. (B, C) DNMT1 and DNMT3a were detected at 24 h and 48 h by Western blot. As control, a-tubulin
was blotted. Data are expressed as mean 6 SD from four separate experiments. *P,0.05 as compared with Sham; #P,0.05 as compared with H24 h;
Sham, normoxia; H48h, hypoxia 48 h; Ume, unmethylated; Meth, methylation.
doi:10.1371/journal.pone.0019229.g006
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and used either for Western blotting.
Real-Time PCR Analysis
Total RNA from cultures was prepared using Trizol reagent
(Invitrogen, USA) and digested with RNase-free DNase for 30 min
to exclude genomic DNA contamination. For RT-PCR analysis,
2 mg of RNA was transcribed into cDNA with the Reverse
Transcription System (Promega, USA) and oligo (dT) primers in a
20-ml volume. The abundance of transcripts in cDNA samples was
measured by RT-PCR with primer as follows: NEP forward, 5-
’ATCCAACGAATGTGTTAAGGA-39, reverse, 5-’GTAA GC-
GTGAGCGCACTAAA-39; GAPDH forward, 59-CCATGTTT-
GTGATGGGTGTGAACCA-39, reverse, 59-ACCAGTG GAT-
GCAGGGATGATGTTC-39 (Sangon Biotech, China). Real-time
PCR was performed by Chromo 4 Sequence Detection System
(Bio-Rad, USA) utilizing a SYBR Green PCR premix reagent
(Toyobo, Japan). The PCR reaction was set up as follows: initial
denaturation at 95uC for 10 min, followed by 40 cycles of 15 s at
95uC, 15 s at 58uC and 30 s at 72uC. The levels of NEP
expression were normalized to GAPDH.
Western blot assay
For Western blot assay, cells were washed three times with cold
PBS (pH 7.2), and then harvested with a cell scraper, and lysed in
cold lysis buffer (modified RIPA) after centrifugation. The protein
concentrations were determined by the method of BAC. Equal
amounts of protein (60 mg/lane) were separated on polyacryl-
amide gels and then electrotransferred onto a nitrocellulose
membrane (Amersham, UK). After blocking for 3 h in Tris-
buffered saline with 0.1% Tween-20 (TBST) and 3% bovine
serum albumin (BSA), membranes were incubated overnight at
4uC with primary antibodies: H3K9me2 and H3K4me3 at 1:500
(Upstate, USA, a generous gift from Prof. Degui Chen, The
Shanghai Institute of Biochemistry and Cell Biology, Chinese
Academy of Sciences), H3-Ace at 1:500 (Santa Cruz Biotechnol-
ogy, USA), NEP at 1:500 (Santa Cruz Biotechnology, USA),
Dnmt1 and Dnmt3a at 1:500 (Santa Cruz Biotechnology, USA).
Membranes were then washed and incubated with alkaline
phosphatase conjugated secondary antibodies in TBST for 2 h
and developed using NBT/BCIP substrate (Promega, USA). The
densities of the bands on the membrane were scanned and
analyzed with an image analyzer (Lab Works Software, USA).
Immunofluorescent staining
For immunofluorescent staining, cells were washed three times in
D-Hanks’ and then fixed for 15 min at 37uC in 4% PFA. After
incubation with PBS containing 0.2% Triton X-100, 5% BSA for
30 min atroomtemperature(RT), theneuronswere incubatedwith
primary antibodies (H3K9me2 at 1:300, Upstate, USA; H3-Ace at
1:300, Santa Cruz Biotechnology) overnight at 4uC. After washing,
the cells were then incubated with secondary antibody (Cy2-
conjugated anti-mouse IgG at 1:200, Jackson, USA) at RT for 2 h.
Chromatin immunoprecipitation assay and qPCR Analysis
A ChIP assay was performed using aChIPassay kit(Upstate,USA)
according to the manufacturer’s protocol with slight modifications.
Briefly, cells were cross-linked with 1% formaldehyde (Sigma, USA)
in a culture medium at RT for 10 min. Cells were then suspended in
SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.1 and
1 6 protease inhibitor) and sonicated on ice. Next, the chromatin
solution was precleared, incubated with anti-H3-Ace or anti-
H3K9me2 antibodies (Upstate, USA), and immune complexes were
eluted. DNA recovered from the immunoprecipitated complex was
subjected to PCR with 38 cycles [36]. The primers for the NEP gene
promoters were promoter-1: Forward, 59- TTCCCTGAAGTCAG-
GAGGTG-39,r e v e r s e5 9-CCTCCCTCCTTCGTTTTCTT-39
(177bp); promoter-2 forward, 59-AGATGTGCAAGTGGCG-
GAAG-39, reverse, 59-CGCACCCACAG AGACTCAC-39
(150 bp); DNA bands were visualized and semi-quantified using the
Image J program (NIH, Bethesda, MD, USA).
Methylation-specific PCR and unmethylation-specific PCR
GenomicDNAwasextractedbyastandardproteinaseKdigestion
and phenol chloroform procedure. Genomic DNA was modified by
EZ DNA Methylation Direct
TM Kit (Zymo Research, USA)
according to the manufacturer’s protocol. After modification, PCR
amplifications were performed with 40 cycles at 95uC for 30 s, 57–
62uCf o r3 0sa n d7 2 uC for 30 s in a Pelrier Thermal Cycler (Bio-
RAD, USA). The primer sequences for the unmethylated products
were promoter-1: forward, 59-TTCCCTGAAGTCAGGAGGTG-
39, reverse, 59-CCTCCCTCCTTCGTTTTCTT-39 (177 bp); pro-
moter-2: forward, 59-AGATGTG CAAGTGGCGGAAG-39,r e -
verse, 59-CGCACCCACAGAGACTCAC-39 (150 bp); The primer
sequences for the methylated products were MS-promoter-1:
forward, 59-GAAC TCCGAACGAATAAACG-39, reverse, 59-
ATTTAGGGAATTGTTTTCGC-39 (183 bp); MSpromoter-2:
forward, 59-TTCTGGTTCTGTTCTGTTGTGTG-39, reverse,
59-TCCCAA CCAATAAACACACCAA-39 (165 bp).
Transient transfection and siRNA silencing
One double-stranded siRNAs designed to target G9a and
HDAC1, and a scrambled siRNA were synthesized as control (Gene
Pharma Co., Ltd, China). Transfection with Lipofectamine 2000
(Invitrogen, USA) was performed according to the manufacturer’s
protocol. Mouse primary cortical and hippocampal neurons were
transfected with 100 nM duplexes targeted to G9a and HDAC1, and
a scrambled siRNA were treated as control before hypoxia. G9a and
HDAC1 protein expression were evaluated by Western blot after
24 h post-transfection. SiRNA for G9a were designed to target 59-
AAGCTCTAACTGAACAACTAA-39 and 59-CACCATGAA-
CATCGATCGCAA-39, and siRNAs for HDAC1 were designed
to target 59-CACC CGGAGGAAAGTCTGTTA-39 and 59-GAC-
GAGTCCTATGAGGCCATT-39 [25].
Statistical analysis
Significant differences between experimental groups were
determined using one-way analysis of variance (ANOVA) with
Sigma Stat. P value of less than 0.05 was considered to have
significant difference. The quantitative data were obtained from 4
to 5 independent assays with duplication in each assay.
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